These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6980110

  • 1. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB, Reis TC, Berland JE.
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selection of an oral erythromycin product.
    Fraser DG.
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
    Bérubé D, Kirouac D, Croteau D, Bergeron MG, Lebel M.
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1227-30. PubMed ID: 3142349
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P, Kaojarern S, Kusmiesz H, Nelson JD.
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythromycin propionate and estolate.
    Farre M.
    Lancet; 1988 Jul 02; 2(8601):45. PubMed ID: 2898648
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D, Csuka ME, Blanchard B.
    JAMA; 1980 Mar 14; 243(10):1074. PubMed ID: 6965509
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cholestatic hepatitis caused by erythromycin estolate].
    García Monzón C, Noguerado A, Hidalgo S, Escudero V.
    Rev Clin Esp; 1985 Nov 14; 177(8):420-1. PubMed ID: 3836470
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk-benefit equation for erythromycin estolate.
    LeBel M.
    Am J Hosp Pharm; 1980 Feb 14; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.